True Wealth Design LLC purchased a new position in Tenet Healthcare Co. (NYSE:THC – Free Report) in the third quarter, HoldingsChannel.com reports. The fund purchased 229 shares of the company’s stock, valued at approximately $38,000.
A number of other large investors have also made changes to their positions in the stock. Optas LLC lifted its holdings in Tenet Healthcare by 3.4% in the 3rd quarter. Optas LLC now owns 2,821 shares of the company’s stock valued at $469,000 after purchasing an additional 93 shares in the last quarter. Signaturefd LLC lifted its stake in shares of Tenet Healthcare by 17.6% during the third quarter. Signaturefd LLC now owns 628 shares of the company’s stock valued at $104,000 after buying an additional 94 shares during the period. CIBC Asset Management Inc grew its stake in Tenet Healthcare by 3.4% in the 3rd quarter. CIBC Asset Management Inc now owns 2,887 shares of the company’s stock worth $480,000 after acquiring an additional 94 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Tenet Healthcare by 20.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 560 shares of the company’s stock valued at $74,000 after acquiring an additional 96 shares during the last quarter. Finally, First Citizens Bank & Trust Co. boosted its holdings in shares of Tenet Healthcare by 5.1% during the third quarter. First Citizens Bank & Trust Co. now owns 2,226 shares of the company’s stock worth $370,000 after purchasing an additional 109 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on THC shares. KeyCorp began coverage on Tenet Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $200.00 target price on the stock. Barclays increased their price objective on shares of Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. The Goldman Sachs Group upped their price target on shares of Tenet Healthcare from $173.00 to $196.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Royal Bank of Canada boosted their price objective on shares of Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $190.00 target price (up from $180.00) on shares of Tenet Healthcare in a research report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $168.19.
Tenet Healthcare Stock Up 0.5 %
Shares of NYSE:THC opened at $142.68 on Monday. The company has a 50 day moving average of $156.87 and a two-hundred day moving average of $148.62. Tenet Healthcare Co. has a 52-week low of $66.64 and a 52-week high of $171.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35. The company has a market capitalization of $13.57 billion, a price-to-earnings ratio of 4.57, a price-to-earnings-growth ratio of 0.64 and a beta of 2.15.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The firm had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.05 billion. During the same quarter in the previous year, the business posted $1.44 EPS. The firm’s revenue was up 1.1% compared to the same quarter last year. As a group, analysts forecast that Tenet Healthcare Co. will post 11.38 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $155.94, for a total value of $623,760.00. Following the completion of the sale, the executive vice president now owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider R. Scott Ramsey sold 11,599 shares of Tenet Healthcare stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $162.06, for a total value of $1,879,733.94. Following the completion of the transaction, the insider now owns 6,324 shares of the company’s stock, valued at $1,024,867.44. This trade represents a 64.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.93% of the stock is owned by company insiders.
Tenet Healthcare Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
- Five stocks we like better than Tenet Healthcare
- Investing In Automotive Stocks
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Upcoming IPO Stock Lockup Period, Explained
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Compound Interest and Why It Matters When Investing
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.